Category

• Pipeline3

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Glaucoma3
• Ocular Hypertension2
• Clinical Trials2
• Eye Drops2
• Eye Drop Solution1

• Organizations: Skye Bioscience✕

Clear all

Pipeline

Skye shifting away from eye care after phase 2 glaucoma study fails

Clinical trial evaluating SBI-100 OE did not achieve statistical significance in improving IOP for patients with POAG and OHT.

Pipeline

Skye Bioscience concludes enrollment for phase 2 glaucoma, OHT trial

Study is evaluating SBI-100 ophthalmic emulsion, formulated to modulate IOP.

Pipeline

Positive safety review for phase 1 study of SBI-100 for glaucoma

Safety review committee gives green light for Skye Bioscience’s second cohort.